Under the leadership of its manager, Carl Harald Janson, International Biotechnology Trust (IBT) is building a track record of outperformance of both its benchmark, the Nasdaq Biotechnology Index and the average of its peer group (see page 13 of this note for the figures).
19 Jul 2018
Outperformance and income
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Outperformance and income
International Biotechnology Trust PLC (IBT:LON) | 610 -12.2 (-0.3%) | Mkt Cap: 230.8m
- Published:
19 Jul 2018 -
Author:
Ed Marten -
Pages:
19
Under the leadership of its manager, Carl Harald Janson, International Biotechnology Trust (IBT) is building a track record of outperformance of both its benchmark, the Nasdaq Biotechnology Index and the average of its peer group (see page 13 of this note for the figures).